Rhenman & Partners Asset Management AB Lowers Stock Position in Ionis Pharmaceuticals, Inc. $IONS
MarketBeat
Rhenman & Partners Asset Management AB lessened its holdings in Ionis Pharmaceuticals, Inc. (NASDAQ:IONS - Free Report) by 48.9% in the 4th quarter, according to its most recent filing with the SEC. The firm owned 158,500 shares of the company's stock after selling 151,500 shares during the period.
NASDAQ:IONS